While it shows potential for promoting tissue repair and reducing inflammation, its premature to label it a cure for chronic conditions without more robust clinical data
Evidence was reported according to the neuropsychiatric condition under investigation: cognitive disorders (dementia, Parkinsons disease), substance-use disorders, psychotic disorders, mood and anxiety disorders, and eating disorderseach subdivided into pre-clinical and mechanistic evidence, and clinical evidence, the latter reported following a hierarchy of evidence (that is, meta-analyses, clinical trials, observational studies, case series)
The acquisition included Kai7535, a small molecule oral GLP-1 agonist and an oral version of dual agonist KAI-9531
As they figure stuff out, they have to share it back with the University of Toronto to improve the manufacturing yields of whoever else will be developing the drug